期刊文献+

扩增和纯化携带肌浆网钙ATP酶重组腺病毒的实验方法

Experimental Method on Amplification and Purification of Adenovirus Mediated Sarcoplasmicreticulum Ca^(2+) ATPase
在线阅读 下载PDF
导出
摘要 目的:通过扩增和纯化rAd.SERCA2a,为转SERCA2a基因研究提供实验基础,并为建立基因库提供稳定可靠的实验方法。方法:用100μL 1.9×1012 pfu/ml rAd.SERCA2a感染HEK293细胞,出现细胞病变效应时收获细胞,经物理反复冻融方法及两步氯化铯超速离心方法获得纯化的rAd.SERCA2a,紫外分光光度计比色法测定病毒DNA质粒数。结果:rAd.SERCA2a成功在HEK293细胞表达呈现绿色荧光,纯化的rAd-SERCA2a-GFP DNA质粒数为1.3±0.58×1012 pfu/mL,OD260/OD280比值为1.57±0.49(n=50)。结论:建立了稳定可靠的借助HEK293细胞培养扩增rAd.SERCA2a的实验方法,纯化后的高效价的SERCA2a基因的重组腺病毒可直接用于心力衰竭的实验研究,对重组腺病毒携带其他基因的扩增与提纯方法也具有一定的参考价值。 Objective:This study provided stable and efficient methods for sarcoplasmicreticulum Ca2+ ATPase(SERCA2a) gene bank and established the basis of transferring gene experiments by amplification and purification of recombinant adenovirus(rAd) mediated SERCA2a gene.Method:Human embryonic kidney(HEK) 293 cells were transfected by adenovirus mediated SERCA2a gene with 100μL at virus concentration of 1.9 × 1012 pfu/mL,when the cells appeared cytopathic effect(CPE),collected and destroyed cell wall with freeze-thaw steps to deliver virus,got the Ad-SERCA2a-GFP products by 2×CsCl-gradient purification and measured DNA plasmids by the ultraviolet spectrophotometer.Result: Green fluorescence were successfully expressed in HEK293 cells.The infectious titer,the number of virus particle and the ratio of infectious titer to virus particle for the product were 1.3±0.58×1012 pfu/mL,The OD260/OD280 ratio was 1.57±0.49(n=50).Conclusion:We established the reliably experimental method for amplification of rAd.SERCA2a by HEK 293 cells,and provided high titer rAd.SERCA2a for gene therapy research of heart failure,as well as had certainly referred values for the amplification and purification of recombination adenovirus carrying other genes.
出处 《生物技术》 CAS CSCD 北大核心 2011年第2期53-56,共4页 Biotechnology
基金 新疆维吾尔自治区自然科学基金项目("肌浆网钙ATP酶基因转导治疗急性心肌梗塞的实验研究" 2009211B18)资助
关键词 HEK293细胞 腺病毒 SERCA2A 扩增 纯化 HEK-293 cells adenovirus sarcoplasmicreticulum Ca2+ ATPase amplification purification
  • 相关文献

参考文献13

  • 1Sudhish Mishra,Hani N.Sabbah,Sharad Rastogi,et al.Reduced sarcoplasmicreticulum Ca2+ uptake and increased Na《'+》-Ca2+ exchanger expression in left ventricle myocardium of dogs with progression of heart failure[J].Heart and Vessels,2005,20(1):23-32.
  • 2Jutta Weisser-Thomas,Hajime Kubo,Colleen A.Hefner,et al.The Na^+/Ca^2+ exchanger/ SR Ca^2+ ATPase transport capacity regulates the contractility of normal and hypetrophied feline ventricular myocytes[J].Journal of Cardiac Failure,2005,11 (5):380-387.
  • 3惠海鹏,李小鹰,刘秀华,孙胜,鲁晓春,刘涛,杨伟.腺相关病毒介导心肌肌浆网Ca^(2+)-ATPase2a基因转导治疗大鼠慢性心力衰竭[J].中华心血管病杂志,2006,34(4):357-362. 被引量:22
  • 4Michael I.Miyamoto,Federica del Monte,Ulrich Schmidt,et al.Adenovirul gene transfer if SERCA2a improves left ventrieular function in aortic banded rat s in transition to heart failure[J].Proc Natl Acad Sci,2000,97(2):793-98.
  • 5Hung Ly,Yoshiaki Kawase,Ryuichi Yoneyama,et al.Gene therapy in the treatment of heart failure[J].Physiology (Bethesda),2007,22(2):81-96.
  • 6Roger J.Hajjar,Jing X.Kang,Judith K.Gwathmey,et al.Physiological Effects of Adenoviral Gene Transfer of Sarcoplasmic Reticulum Calcium ATPase in Isolated Rat Myoeytes[J].Circulation,1997,95(2):423-429.
  • 7Roger J.Hajjar,Krisztina Zsebo,Lawrence Deekelbaum,et al.Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure[J].J Card Fail,2008,14(5):355 367.
  • 8Valérie Cortin,Jules Thibault,Danielle Jacob,et al.High-titer adenovirus vector production in 293 cell perfusion culture[J].Biotechnoiogy Progress,2004,20(3):858-863.
  • 9Naxin Wu,Mohammad M Ataai.Production of Viral Vectors for Gene Therapy Applications[J].Current Opinion in Bintechnology,2000,11 (2):205-208.
  • 10Hung Q.Ly,Yoshiaki Kawase,Roger J.Hajjar.Advances in Gene -Based Therapy for Heart Failure[J].J,of Cardiovasc.Trans.Res.,2008,1(2):127-136.

二级参考文献44

  • 1惠海鹏,李小鹰,彭江.大鼠经腹心包腔内注射术的研究[J].医学研究生学报,2005,18(10):879-881. 被引量:7
  • 2陈枫,赵新华,刘安敏.HBsAg腺病毒疫苗载体的构建及293细胞中的包装表达[J].中国免疫学杂志,2006,22(12):1137-1139. 被引量:3
  • 3Mitani K, Graham FL, Caskey CT, et al. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector [ J ] . Proc Natl Acad Sci USA, 1995, 92 (9): 3854- 3858.
  • 4Reiser J, Harmison G, Kluepfel-Stahl S, et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles [J] .Proc Natl Acad Sci USA, 1996, 93 (26): 15266-15271.
  • 5Lee D, Kim NY, Bae GE, et al. Transmissible infection of human 293T cells with porcine endogenous retroviruses subgroup a from NIH-miniature pig [ J ] . Transplant Proe, 2008, 40 ( 10 ):3742-3745.
  • 6Yeh P, Perricaudet M. Advances in adenoviral vectors : from genetic engineering to their biology [J].FASEB J, 1997, 11 ( 8 ): 615-623.
  • 7Hickson-Bick DL, Jones C, Buja LM. Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat eardiomyocyte protects against programmed cell death [ J ]. J Mol Cell Cardiol, 2008, 44 ( 2 ) : 411-418.
  • 8Louis N, Evelegh C, Graham FL. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line[J]. Virology, 1997, 233 ( 2 ) : 423- 429.
  • 9Murakami P, Havenga M, Fawaz F, et al. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches [J]. J Virol, 2004, 78 ( 12 ) : 6200-6208.
  • 10Graham FL, Smiley J, Russell WC, et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5 [J]. J Gen Virol, 1977, 36 (1):59-74.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部